| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma, Cavernous, Central Nervous System | 56 | 2025 | 251 | 9.190 |
Why?
|
| Hemorrhage | 24 | 2023 | 290 | 1.890 |
Why?
|
| rho-Associated Kinases | 11 | 2019 | 161 | 1.730 |
Why?
|
| Brain Neoplasms | 11 | 2022 | 807 | 1.540 |
Why?
|
| Hemangioma, Cavernous | 8 | 2021 | 69 | 1.300 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2021 | 203 | 1.250 |
Why?
|
| Cerebral Hemorrhage | 10 | 2025 | 361 | 1.100 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2011 | 119 | 1.000 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 2445 | 0.980 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 389 | 0.950 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 6 | 2020 | 36 | 0.930 |
Why?
|
| Central Nervous System Neoplasms | 5 | 2019 | 90 | 0.910 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2025 | 3518 | 0.890 |
Why?
|
| NF-kappa B | 14 | 2003 | 465 | 0.840 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2021 | 677 | 0.820 |
Why?
|
| Lung | 19 | 2023 | 1339 | 0.820 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 131 | 0.760 |
Why?
|
| Mice | 45 | 2024 | 12137 | 0.690 |
Why?
|
| Endothelial Cells | 15 | 2024 | 470 | 0.690 |
Why?
|
| KRIT1 Protein | 14 | 2022 | 62 | 0.670 |
Why?
|
| Simvastatin | 2 | 2019 | 106 | 0.640 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2001 | 68 | 0.640 |
Why?
|
| Biomarkers | 17 | 2025 | 1847 | 0.630 |
Why?
|
| Endotoxemia | 6 | 2001 | 19 | 0.600 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 651 | 0.590 |
Why?
|
| Animals | 54 | 2025 | 28055 | 0.550 |
Why?
|
| Membrane Proteins | 6 | 2021 | 1244 | 0.530 |
Why?
|
| Capillary Permeability | 6 | 2021 | 132 | 0.530 |
Why?
|
| Mutation | 12 | 2021 | 4217 | 0.470 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2024 | 66 | 0.430 |
Why?
|
| Sirolimus | 3 | 2024 | 175 | 0.430 |
Why?
|
| Cytokines | 7 | 2017 | 842 | 0.410 |
Why?
|
| Microtubule-Associated Proteins | 9 | 2022 | 184 | 0.410 |
Why?
|
| Male | 57 | 2025 | 43922 | 0.410 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2025 | 389 | 0.410 |
Why?
|
| Propranolol | 3 | 2022 | 44 | 0.400 |
Why?
|
| Neutrophil Activation | 4 | 2002 | 11 | 0.390 |
Why?
|
| Humans | 63 | 2025 | 92335 | 0.380 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 598 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 16 | 2002 | 1104 | 0.340 |
Why?
|
| Brain | 10 | 2020 | 2355 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2024 | 403 | 0.320 |
Why?
|
| Transcriptome | 5 | 2024 | 700 | 0.310 |
Why?
|
| Carrier Proteins | 6 | 2019 | 678 | 0.310 |
Why?
|
| Adult | 24 | 2025 | 27555 | 0.300 |
Why?
|
| MicroRNAs | 2 | 2025 | 576 | 0.300 |
Why?
|
| Mice, Knockout | 9 | 2024 | 2102 | 0.290 |
Why?
|
| Neutrophils | 6 | 2002 | 323 | 0.290 |
Why?
|
| Female | 37 | 2025 | 47910 | 0.290 |
Why?
|
| Resuscitation | 5 | 1995 | 113 | 0.290 |
Why?
|
| Iron | 4 | 2018 | 175 | 0.280 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 1592 | 0.270 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2023 | 42 | 0.270 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 95 | 0.270 |
Why?
|
| Lipopolysaccharides | 6 | 2020 | 301 | 0.260 |
Why?
|
| Young Adult | 12 | 2025 | 6619 | 0.250 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2023 | 15 | 0.240 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2021 | 105 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 275 | 0.230 |
Why?
|
| Macrophages, Alveolar | 5 | 2000 | 62 | 0.230 |
Why?
|
| Prospective Studies | 9 | 2025 | 4464 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 1275 | 0.220 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2024 | 8 | 0.220 |
Why?
|
| Chemokine CX3CL1 | 1 | 2024 | 6 | 0.220 |
Why?
|
| Middle Aged | 22 | 2025 | 27048 | 0.220 |
Why?
|
| Adolescent | 12 | 2025 | 9492 | 0.220 |
Why?
|
| RNA, Messenger | 13 | 2021 | 2037 | 0.220 |
Why?
|
| B-Lymphocytes | 5 | 2018 | 753 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 4 | 2024 | 355 | 0.210 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 549 | 0.210 |
Why?
|
| Astrocytes | 2 | 2021 | 144 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2003 | 704 | 0.200 |
Why?
|
| Disease Progression | 4 | 2021 | 1500 | 0.200 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2022 | 69 | 0.200 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 161 | 0.200 |
Why?
|
| Cohort Studies | 8 | 2025 | 2979 | 0.200 |
Why?
|
| Child, Preschool | 7 | 2020 | 3806 | 0.200 |
Why?
|
| Gene Expression | 4 | 2003 | 1310 | 0.190 |
Why?
|
| Signal Transduction | 6 | 2024 | 3509 | 0.190 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 45 | 0.190 |
Why?
|
| Plasma Cells | 3 | 2020 | 86 | 0.190 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 14 | 0.190 |
Why?
|
| Catecholamines | 2 | 1999 | 92 | 0.180 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2021 | 7 | 0.170 |
Why?
|
| Child | 8 | 2020 | 7307 | 0.170 |
Why?
|
| ADAMTS5 Protein | 1 | 2020 | 4 | 0.170 |
Why?
|
| Versicans | 1 | 2020 | 7 | 0.170 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 213 | 0.170 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 52 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 3374 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 2 | 2021 | 13 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 610 | 0.170 |
Why?
|
| Gene Deletion | 3 | 2020 | 354 | 0.170 |
Why?
|
| Brain Stem | 1 | 2021 | 166 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 923 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 91 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 226 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 50 | 0.160 |
Why?
|
| Xanthine Oxidase | 4 | 2001 | 25 | 0.160 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 75 | 0.160 |
Why?
|
| Autoantigens | 1 | 2020 | 137 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 741 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2020 | 277 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2001 | 444 | 0.150 |
Why?
|
| Stroke | 3 | 2023 | 1038 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 230 | 0.140 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 1996 | 130 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1150 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 192 | 0.140 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 21 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 1999 | 503 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 2009 | 0.130 |
Why?
|
| Permeability | 3 | 2021 | 141 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2017 | 2905 | 0.130 |
Why?
|
| Temporal Arteries | 2 | 2009 | 9 | 0.130 |
Why?
|
| Aged | 11 | 2025 | 19946 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 1996 | 189 | 0.120 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 3775 | 0.120 |
Why?
|
| Endothelium, Vascular | 4 | 2020 | 432 | 0.120 |
Why?
|
| Bayes Theorem | 3 | 2022 | 391 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1118 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 2399 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2019 | 86 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 199 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 170 | 0.120 |
Why?
|
| Pregnatrienes | 1 | 1995 | 14 | 0.110 |
Why?
|
| P-Selectin | 1 | 1995 | 13 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2017 | 377 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 75 | 0.110 |
Why?
|
| Genes, MHC Class II | 2 | 1993 | 30 | 0.110 |
Why?
|
| Seizures | 1 | 2017 | 315 | 0.110 |
Why?
|
| Keratin-1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 431 | 0.110 |
Why?
|
| Stress Fibers | 1 | 2014 | 24 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1480 | 0.110 |
Why?
|
| Peyer's Patches | 1 | 1994 | 18 | 0.110 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 88 | 0.110 |
Why?
|
| Infant | 2 | 2014 | 3206 | 0.100 |
Why?
|
| Vitamin D | 1 | 2016 | 269 | 0.100 |
Why?
|
| Contrast Media | 4 | 2021 | 1077 | 0.100 |
Why?
|
| Antioxidants | 1 | 1995 | 223 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2017 | 441 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 1398 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 694 | 0.100 |
Why?
|
| Machine Learning | 3 | 2021 | 304 | 0.100 |
Why?
|
| Recombination, Genetic | 2 | 1993 | 442 | 0.100 |
Why?
|
| Chemokine CXCL2 | 3 | 2001 | 16 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 332 | 0.090 |
Why?
|
| Acute Disease | 3 | 2020 | 852 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 232 | 0.090 |
Why?
|
| Deoxyribonuclease I | 1 | 1991 | 30 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 146 | 0.090 |
Why?
|
| Base Sequence | 9 | 2005 | 2324 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2020 | 966 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2793 | 0.080 |
Why?
|
| Inflammation | 4 | 2011 | 1022 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2001 | 694 | 0.080 |
Why?
|
| Genotype | 4 | 2021 | 1865 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 2012 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2001 | 31 | 0.080 |
Why?
|
| Perfusion | 2 | 2021 | 261 | 0.080 |
Why?
|
| Transcription Factors | 4 | 2000 | 1691 | 0.080 |
Why?
|
| Observer Variation | 3 | 2016 | 611 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 2503 | 0.080 |
Why?
|
| Interferon-gamma | 3 | 1996 | 456 | 0.080 |
Why?
|
| Ethers | 1 | 2008 | 14 | 0.070 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 46 | 0.070 |
Why?
|
| Microdissection | 1 | 2008 | 18 | 0.070 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 54 | 0.070 |
Why?
|
| Medical Illustration | 1 | 2008 | 16 | 0.070 |
Why?
|
| Magnetics | 1 | 2008 | 41 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2025 | 1754 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 245 | 0.070 |
Why?
|
| Lasers | 1 | 2008 | 103 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2008 | 77 | 0.070 |
Why?
|
| Fluorocarbons | 1 | 2008 | 71 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 82 | 0.070 |
Why?
|
| Oligoclonal Bands | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2018 | 23 | 0.070 |
Why?
|
| Myocardium | 2 | 2003 | 586 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2021 | 524 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 200 | 0.070 |
Why?
|
| Cell Movement | 3 | 1999 | 801 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 460 | 0.070 |
Why?
|
| Endotoxins | 2 | 1999 | 38 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2020 | 674 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1986 | 24 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 8724 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 3122 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 3023 | 0.060 |
Why?
|
| Interleukin-1 | 3 | 2000 | 71 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 697 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2020 | 900 | 0.060 |
Why?
|
| Moyamoya Disease | 1 | 2025 | 21 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 66 | 0.060 |
Why?
|
| Laminin | 1 | 2005 | 93 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1891 | 0.050 |
Why?
|
| DNA Repair | 2 | 1986 | 368 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 607 | 0.050 |
Why?
|
| Transcription Factor RelA | 2 | 2001 | 49 | 0.050 |
Why?
|
| Fibronectins | 1 | 2005 | 102 | 0.050 |
Why?
|
| Myosins | 1 | 2005 | 94 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1723 | 0.050 |
Why?
|
| Chemokines | 2 | 2001 | 74 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 101 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2005 | 131 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 226 | 0.050 |
Why?
|
| Interleukins | 2 | 1995 | 134 | 0.050 |
Why?
|
| Phentolamine | 2 | 2001 | 8 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 1173 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 1282 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 144 | 0.050 |
Why?
|
| Collagen | 1 | 2005 | 305 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 5428 | 0.050 |
Why?
|
| Genomics | 1 | 2009 | 806 | 0.050 |
Why?
|
| Peroxidase | 2 | 2000 | 52 | 0.050 |
Why?
|
| Aging | 2 | 2020 | 741 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2022 | 34 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2003 | 57 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 79 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1803 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 129 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 358 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 6916 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 166 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2003 | 185 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 469 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2001 | 16 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2009 | 392 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 14 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 67 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2003 | 523 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 82 | 0.040 |
Why?
|
| Tungsten | 1 | 2001 | 5 | 0.040 |
Why?
|
| Cell Line | 3 | 1996 | 2503 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 99 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 40 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2011 | 33 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 245 | 0.040 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2001 | 15 | 0.040 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 22 | 0.040 |
Why?
|
| Patient Participation | 1 | 2023 | 227 | 0.040 |
Why?
|
| Animal Feed | 1 | 2001 | 21 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 70 | 0.040 |
Why?
|
| ADAMTS4 Protein | 1 | 2020 | 4 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 47 | 0.040 |
Why?
|
| ADAMTS1 Protein | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 77 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2000 | 24 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 39 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 39 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2020 | 148 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cholecalciferol | 1 | 2020 | 35 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 51 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 98 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2003 | 725 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 108 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 49 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 107 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 167 | 0.040 |
Why?
|
| Tubulin | 1 | 2020 | 60 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 122 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 307 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 91 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 277 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2019 | 69 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 523 | 0.040 |
Why?
|
| Monokines | 1 | 1999 | 3 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 209 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 86 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2021 | 152 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1519 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 95 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 247 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 184 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 306 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 257 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 689 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 33 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 295 | 0.040 |
Why?
|
| Hypoxia | 1 | 2024 | 670 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1297 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 316 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 460 | 0.040 |
Why?
|
| Occludin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 326 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 348 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 252 | 0.040 |
Why?
|
| DNA Replication | 4 | 1986 | 175 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 85 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2021 | 424 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 669 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 347 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 340 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1238 | 0.030 |
Why?
|
| Methylation | 2 | 1991 | 281 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 337 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 36 | 0.030 |
Why?
|
| Intestines | 1 | 2020 | 426 | 0.030 |
Why?
|
| Germ-Free Life | 1 | 2017 | 78 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 238 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 1248 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 315 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 291 | 0.030 |
Why?
|
| Colitis | 1 | 2019 | 253 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 273 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 313 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 478 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1996 | 37 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 800 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2016 | 36 | 0.030 |
Why?
|
| Cerebellum | 1 | 2018 | 251 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1996 | 11 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 39 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 377 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 381 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 37 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2016 | 11 | 0.030 |
Why?
|
| Clone Cells | 1 | 1996 | 214 | 0.030 |
Why?
|
| Catalase | 1 | 1996 | 48 | 0.030 |
Why?
|
| Iodine | 1 | 2016 | 44 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 208 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 56 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 786 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 702 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 155 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 373 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 186 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 672 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1743 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 4 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 887 | 0.030 |
Why?
|
| Spleen | 1 | 1996 | 435 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 203 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 212 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 815 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1144 | 0.030 |
Why?
|
| Models, Biological | 2 | 2020 | 1784 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 19 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 9 | 0.030 |
Why?
|
| Meiosis | 2 | 1993 | 84 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2370 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1994 | 101 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 122 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1994 | 204 | 0.030 |
Why?
|
| Gadolinium | 1 | 2013 | 104 | 0.030 |
Why?
|
| Monocytes | 1 | 1994 | 223 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3875 | 0.020 |
Why?
|
| Apoptosis | 1 | 1999 | 1736 | 0.020 |
Why?
|
| Pneumonia | 1 | 1994 | 187 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 1138 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2014 | 473 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 306 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1574 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 808 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1996 | 969 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 152 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2015 | 404 | 0.020 |
Why?
|
| Breeding | 1 | 2010 | 41 | 0.020 |
Why?
|
| Testis | 1 | 1991 | 152 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 293 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Edema, Cardiac | 1 | 2010 | 3 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2013 | 581 | 0.020 |
Why?
|
| Genes | 1 | 1991 | 307 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2010 | 29 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 25 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 302 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 53 | 0.020 |
Why?
|
| Brain Edema | 1 | 2010 | 61 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 59 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 43 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 87 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1135 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 184 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 560 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 102 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 531 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 696 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1986 | 239 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 48 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2000 | 612 | 0.020 |
Why?
|
| Mitosis | 1 | 1986 | 156 | 0.020 |
Why?
|
| Kinetics | 2 | 1986 | 1552 | 0.020 |
Why?
|
| DNA Polymerase I | 1 | 1986 | 9 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1228 | 0.020 |
Why?
|
| Macrophages | 1 | 2009 | 601 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 309 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 475 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 186 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 453 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1986 | 613 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 4063 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 160 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2000 | 1921 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1986 | 623 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 876 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 1143 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2074 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 266 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 589 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 1 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 27 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 217 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 360 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2000 | 42 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2000 | 137 | 0.010 |
Why?
|
| DNA | 1 | 1985 | 1314 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 284 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 146 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1997 | 14 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 78 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1997 | 111 | 0.010 |
Why?
|
| Templates, Genetic | 2 | 1985 | 33 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 300 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 7 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 39 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 451 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1985 | 93 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 52 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 583 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1995 | 436 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 371 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 288 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 1045 | 0.010 |
Why?
|
| Transfection | 1 | 1993 | 901 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1993 | 771 | 0.000 |
Why?
|
| Larva | 1 | 1986 | 123 | 0.000 |
Why?
|
| Sulfuric Acid Esters | 1 | 1985 | 4 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1985 | 16 | 0.000 |
Why?
|
| Alkylating Agents | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 385 | 0.000 |
Why?
|
| Adenine | 1 | 1985 | 90 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1985 | 997 | 0.000 |
Why?
|